Anika Therapeutics Inc. (ANIK)
NASDAQ · Healthcare
Anika Therapeutics Inc. Operating Income 2009–2025
Anika Therapeutics Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Anika Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -5.5 M, a 28.10% increase year-over-year.
- Anika Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -17.2 M, a 42.38% increase year-over-year.
- Anika Therapeutics Inc. annual operating income for 2025 was -11.1 M, a 116.64% increase from 2024.
- Anika Therapeutics Inc. annual operating income for 2024 was -5.1 M, a 704.38% decrease from 2023.
- Anika Therapeutics Inc. annual operating income for 2023 was 844000, a 77.00% decrease from 2022.
- Anika Therapeutics Inc. annual operating income for 2022 was 3.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Anika Therapeutics Inc. Operating Income — FAQ
Anika Therapeutics Inc. (ANIK) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Anika Therapeutics Inc.'s operating income?
Anika Therapeutics Inc. (ANIK) reported operating income of -$11M for fiscal 2025.
Where can I see ANIK's operating income history?
The chart and table above show Anika Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.